Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

NCT04138485 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Due to business reasons, not safety issues

Conditions

Diffuse Cutaneous Systemic Sclerosis

Interventions

BIOLOGICAL: IgPro10
BIOLOGICAL: Placebo

Sponsor

CSL Behring